Directory
>
Fred D'amato
Fred D'amato
Executive Director | Kura Oncology, Inc.
Boston, Massachusetts, United States
Fred D'amato
Summary
Fred D'amato is an accomplished Executive Director at Kura Oncology, Inc., with over 15 years of extensive experience in clinical program management and operations. He holds a Master of Science in Pharmacology and has a proven track record in leading multi-national studies involving small molecules and biologics, particularly in orphan indications. His expertise spans several therapeutic areas, including oncology, neurology, and hemophilia. Fred has a keen interest in novel study designs and emerging markets, showcasing his innovative approach to clinical research. He has held various leadership roles, demonstrating a strong ability to manage cross-functional teams effectively. His career reflects a commitment to advancing clinical trials and improving patient outcomes through rigorous research methodologies.
Fred D'amato
Work Experience
Executive Director at
Kura Oncology, Inc.
December 2023 - Present
Sr. Director - Clinical Operations Lead at
Kura Oncology, Inc.
June 2022 - December 2023
Director - Clinical Operations Lead at
Kura Oncology, Inc.
September 2020 - June 2022
Director - Gene Therapy, Clinical Operations at
Sarepta Therapeutics
February 2019 - September 2020
Associate Director Clinical Operations at
Sarepta Therapeutics
April 2018 - February 2019
Associate Director, Clinical Program Support at
Shire
June 2016 - November 2017
Clinical Program Lead, Clinical Operations at
Baxalta
March 2015 - October 2016
Senior Clinical Study Manager at
Takeda Pharmaceuticals America, Inc.
May 2014 - February 2015
Senior Clinical Trial Manager at
Biogen
February 2013 - May 2014
Clinical Trial Manager at
Biogen
February 2009 - February 2013
Sr. Clinical Trial Coordinator/Acting Clinical Trial Manager at
Biogen
September 2007 - February 2009
Clinical Research Associate II at
Dana Farberharvard Cancer Center At Mgh
January 2005 - January 2007
Fred D'amato
Education
January 2005 - January 2007
January 1993 - January 1997
Frequently Asked Questions about Fred D'amato
What is Fred D'amato email address?
Fred D'amato's primary email address is *******@sarepta.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Fred D'amato work for?
Fred D'amato is a Executive Director at Kura Oncology, Inc., a company specializing in Commercial physical research.
Where Fred D'amato graduated from?
Fred D'amato holds a degree in Pharmacology from Northeastern University.
How can I directly contact Fred D'amato?
To contact Fred D'amato directly, you can use the email address *******@sarepta.com. Complete contact information is available upon registration with Muraena.
Who is Fred D'amato?
Fred D'amato is an accomplished Executive Director at Kura Oncology, Inc., with over 15 years of extensive experience in clinical program management and operations. He holds a Master of Science in Pharmacology and has a proven track record in leading multi-national studies involving small molecules and biologics, particularly in orphan indications. His expertise spans several therapeutic areas, including oncology, neurology, and hemophilia. Fred has a keen interest in novel study designs and emerging markets, showcasing his innovative approach to clinical research. He has held various leadership roles, demonstrating a strong ability to manage cross-functional teams effectively. His career reflects a commitment to advancing clinical trials and improving patient outcomes through rigorous research methodologies.
Fred`s contact details
*******@sarepta.com
***********@takeda.com
*******@kuraoncology.com
Colleagues
Executive Director Clinical Data Sciences
Executive Vice President, Investor Relations & Corporate Communications
Chief Legal Officer
Senior Vice President, Finance and Accounting & Principal Accounting Officer
Executive Vice President Clinical Development
Chief Medical Officer and Head of R&D
Vice President Business Development
Chief Operating Officer
Vice President, Human Resources
Vice President Quality Assurance